XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

Name: XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects
License: Public Domain

The First Affiliated Hospital with Nanjing Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma, b-cell, leukemia, b-cell

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 435754
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.